Senior Embedded Software Engineer to OnDosis 🌟

Why OnDosis

Are you ready for the journey of your life? OnDosis is the new star on the MedTech start-up scene. You will join a company with high ambitions and a goal to revolutionize the medical industry. The company is growing and you will truly impact people's lives.

What will you do

You contribute daily to the overall development at OnDosis, from early ideas all the way to post-launch activities, together with the system engineer and other stakeholders. Our solution is IoT based and you will help build it from scratch, with new technology focused on embedded solutions. Furthermore, you define our architecture and digital strategy. So far so good, right?

Who are you

You are a highly skilled engineer with good knowledge of embedded and end-to-end software architecture. You are meticulous and have no problem with documentation. Good knowledge of the following is also necessary:

- C++ | Python | C | Java

- Linux development

- Semiconductor stacking

- Having worked interdisciplinary with the development of products including embedded SW


A huge super plus if you have experience from Medtech but don't hesitate to apply if you don't 🤩

Perks

30 days vacay
Private healthcare
Yearly bonus
Pension agreement
Cellphone
Flexibility

Reach out to Paula if you have any questions or just want to know a bit more.
paula.olinder@technogarden.se or 0709-197556

About the company

Founded as a spin-out from AstraZeneca in 2017, OnDosis is a Swedish start-up addressing one of the major opportunities in healthcare; personalized dosage of medicines. The proprietary technology platform is centered around a connected handheld device that delivers tailored doses of oral medicines. By combining individual dosing of traditional drug-based medicines augmented by digital therapeutics, OnDosis opens a new chapter in personalized medicine where the mission is to improve patients’ life through delivering the perfect dosage; individualized, intuitive, and intelligent. OnDosis is based in the AstraZeneca BioVenturehub in Mölndal, Sweden.